Barinthus Biotherapeutics plc (BRNS)
Official siteHEALTHCARE • BIOTECHNOLOGY • PINK
Market Cap: $30.23M
Last updated: Nov 13, 2026 at 4:00 PM ET
Barinthus Biotherapeutics plc (BRNS) Competitors
The companies most similar to Barinthus Biotherapeutics are Connect Biopharma Holdings (CNTB), INmune Bio (INMB) and Plus Therapeutics (PSTV). By market cap, Barinthus Biotherapeutics ranks 9th of the 13 companies on this page; Actinium Pharmaceuticals (ATNM) is the largest at $51.56M.
Peer Comparison
BRNS's revenue growth of -100.0% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Barinthus Biotherapeutics (BRNS) | $30.23M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Connect Biopharma Holdings Ltd (CNTB) | $42.65M | N/A | 13.6x | 0.0% | N/A | 5667.0% | 0.00% |
| INmune Bio Inc (INMB) | $32.51M | N/A | N/A | 0.0% | N/A | 257.1% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| ImageneBio, Inc. (IMA) | $43.22M | N/A | 68.5x | 0.0% | N/A | 0.0% | 0.00% |
| Instil Bio Inc. (TIL) | $41.23M | N/A | N/A | 0.0% | -11.9% | 0.0% | 0.00% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | $36.15M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Estrella Immunopharma Inc. (ESLA) | $22.36M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Briacell Therapeutics Corp (BCTX) | $29.60M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| NextCure Inc (NXTC) | $29.31M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| iBio, Inc. Common Stock (IBIO) | $51.55M | N/A | 735.4x | 0.0% | N/A | 975.0% | 0.00% |
| Serina Therapeutics Inc (SER) | $36.93M | N/A | 288.7x | 0.0% | -109.4% | 154.9% | 0.00% |
| Actinium Pharmaceuticals Inc (ATNM) | $51.56M | 4.1x | 1.3x | 32.2% | N/A | -100.0% | 0.00% |
| Peer median | $36.54M | 4.1x | 41.1x | 0.0% | -109.4% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Barinthus Biotherapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Connect Biopharma Holdings Ltd (CNTB) | Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators... | CNTB competitors |
| INmune Bio Inc (INMB) | INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease... | INMB competitors |
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
| ImageneBio, Inc. (IMA) | ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. | IMA competitors |
| Instil Bio Inc. (TIL) | Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients. | TIL competitors |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human... | TELO competitors |
| Estrella Immunopharma Inc. (ESLA) | Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. | ESLA competitors |
| Briacell Therapeutics Corp (BCTX) | BriaCell Therapeutics Corp. The company is headquartered in West Vancouver, Canada. | BCTX competitors |
| NextCure Inc (NXTC) | NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other... | NXTC competitors |
| iBio, Inc. Common Stock (IBIO) | iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States. | IBIO competitors |
| Serina Therapeutics Inc (SER) | Serina Therapeutics Inc is a pioneering biotechnology company focused on developing innovative solutions for unmet medical needs in oncology and neurology... | SER competitors |
| Actinium Pharmaceuticals Inc (ATNM) | Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplantation... | ATNM competitors |
Frequently Asked Questions About BRNS
Who are Barinthus Biotherapeutics' main competitors?
The companies most similar to Barinthus Biotherapeutics include Connect Biopharma Holdings (CNTB), INmune Bio (INMB), Plus Therapeutics (PSTV), ImageneBio (IMA) and Instil Bio (TIL), listed from the closest match.
Who is Barinthus Biotherapeutics' biggest competitor?
Actinium Pharmaceuticals (ATNM) is the largest of the similar companies at $51.56M; Connect Biopharma Holdings (CNTB) is the closest match by business profile, size, sector and industry.
How does BRNS stock compare with its competitors?
BRNS' net margin is 0.0% against a peer median of 0.0%.
Which of Barinthus Biotherapeutics' competitors pays a higher dividend?
Barinthus Biotherapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Barinthus Biotherapeutics bigger than its competitors?
No. Barinthus Biotherapeutics is 9th by market cap among the 13 companies on this page; the largest is Actinium Pharmaceuticals (ATNM) at $51.56M.
BRNS pages: Overview, Earnings, Forecast, Financials, Competitors